coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Angmering Coppice Fitzalan (acf) PCN, Arun · Health Inequalities Profile

    PCN U04748 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    29,460

    Registered population

    55.8% aged 18–64

    25.2%

    Aged 65+

    ICB 21.9% · England 17.9%

    4.5%

    Ethnic minority (non-White)

    1.7% Asian · England 9.6%

    17.1%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~5,142

    Core20 residents (est.)

    Resident basis; registered basis ~8,019 · see page 3

    5,341

    Hypertension register

    +2.07% in 3 yrs · England +5.60%

    404

    SMI register

    20.2% of Arun's

    732

    COPD register

    Reviews -9.33% in 3 yrs

    Forecast to 2030

    5,801

    Hypertension patients, 2030

    +460 on today

    67.0%

    QRISK ≥20% on statins, 2030

    +1.77pp over 3 yrs

    5.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    58.5%
    Respiratory annual reviews trail and contracted.

    Asthma reviews are 58.5% (England 65.7%, -11.1% from 2023 to 2025, about 930 unreviewed patients) and COPD 64.6% (England 76.4%, -9.3%).

    58.7%
    Hypertension blood pressure control trails comparators.

    Under-80 BP control is 58.7% (England 67.8%, Arun 65.6%, -3.1% from 2023 to 2025), 73.9% aged 80+ (England 81.2%) and 62.5% overall.

    96.2%
    Smoking cessation offers and SMI checks grew.

    Smoking cessation offers rose +10.3 pp from 2023 to 2025 to 96.2% (England 94.2%) and SMI BP checks rose +6.6 pp to 82.1%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over make up 25.2% alongside 39 catchment care homes

    Across 29,460 registered patients, 25.2% (7,438) are aged 65+, compared to 29.2% in Arun, 21.9% in NHS Sussex Integrated Care Board, and 17.9% in England. Patients aged 0–17 comprise 19.0% (5,595), against 15.9% in Arun, 17.7% in the ICB, and 19.6% in England. Census usual residents show 95.5% White (Arun 95.8%, ICB 91.0%, England 81.1%) and a 4.5% ethnic minority share. Practice lists sum to 42,956 against the 29,460 PCN total, requiring population base reconciliation.

    Age profile

    0–1719.0%
    18–6455.8%
    65+25.2%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White95.5%
    Mixed1.7%
    Asian1.7%
    Black0.7%
    Other0.4%

    Older people · falls rows are Arun local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Arun LA)2,3272,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)70.7%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.7%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Arun LA)1,2169819552024/25
    Falls deaths, all ages, per 100,000 (Arun LA)13.314.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 17.1% overall and concentrated at Fitzalan Medical Group

    Core20 deprivation is 17.1% across the PCN, exceeding Arun (9.8%) and NHS Sussex Integrated Care Board (9.2%), though below England (21.0%), with an average IMD decile of 5.1. Between practices, Core20 share spans a 27.2 pp range: Fitzalan Medical Group records 27.2% (8,019 estimated patients), while Coppice Surgery records 0.0%. Denominators require reconciliation before targeting, as practice lists total 42,956 against 29,460 PCN registered patients, and resident decile 1 and 2 estimates total 5,142. Targeted Core20 outreach should focus on high-need neighbourhoods once practice list baselines are fully reconciled.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Fitzalan Medical27.2% · 8,019 patients
    Coppice0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    404

    SMI register

    1.35% recorded prevalence

    273

    Learning disability register

    0.92% recorded prevalence

    39

    Care homes, 1,348 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Arun, Census 2021

    The PCN records 404 severe mental illness patients (1.4% vs Arun 1.1%, NHS Sussex Integrated Care Board 1.1%, England 1.0%) and 273 learning disability patients (0.9% vs Arun 0.8%, NHS Sussex Integrated Care Board 0.6%, England 0.6%), alongside 39 catchment care homes with 1,348 beds; bed capacity does not establish registered resident numbers. Higher recorded prevalence than England is consistent with substantial demand for annual health checks alongside care-home liaison.

    Severe mental illness: physical health checks

    SMI prevalence is 1.4% (England 1.0%, 404 patients). Annual physical health checks reached 82.1% for blood pressure (England 83.4%), 81.5% for BMI (England 82.1%), and 79.5% for alcohol consumption (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,341

    Hypertension register

    +2.07%

    Register growth, 3 yrs

    Arun +4.55% · England +5.60%

    −1.90pp

    BP control, under 80

    ≤140/90 · −3.15pp aged 80+

    +460

    More patients by 2030

    Forecast 5,801 (18.65%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 17.9% (5,341 patients), above England (15.2%) and NHS Sussex Integrated Care Board (16.3%), but below Arun (19.8%). However, blood pressure control under age 80 is 58.7%, trailing Arun (65.6%), the ICB (66.8%) and England (67.8%), having fallen 3.1% over 2023 to 2025 (England +3.2%). For patients aged 80+, control is 73.9% (England 81.2%), falling 4.1% (England +2.2%). Across practices, under-80 control is 56.1% at Fitzalan Medical Group and 61.7% at Coppice Surgery. Lower blood pressure control than comparators could reflect recall or medication titration challenges that require clinical review.

    Lipids and statins

    For secondary prevention in diabetes with CVD, statin therapy is 79.8%, trailing England (84.4%), Arun (81.3%) and NHS Sussex Integrated Care Board (81.3%), having fallen -1.9% over 2023 to 2025. Lower secondary-prevention coverage than comparators indicates high-risk diabetic patients are under-protected, making a focused prescribing audit the immediate priority.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202660,251£2.60£2.42£1.86£156,653
    Cardiovascular (all), 202580,218£3.11£3.32£3.33£249,478

    In 2026, lipid-regulating drugs cost £2.60 per item across 60,251 items (annual spend £156,653), compared with £1.86 in England, £2.42 in NHS Sussex Integrated Care Board and £2.81 in Arun. This is £44,586 more than at England's unit cost. Higher unit cost than England could reflect formulary choices that warrant prescribing review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −11.10%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.08%

    Asthma prevalence, PCN 3-yr % change

    Recorded prevalence exceeds England for asthma at 7.9% (England 6.6%, 2,242 patients) and COPD at 2.5% (England 1.9%, 732 patients). Over 2023 to 2025, asthma reviews fell 11.1% to 58.5% (England +4.4% to 65.7%), leaving about 930 unreviewed patients, while COPD reviews fell 9.3% to 64.6% (England +2.8% to 76.4%). Prescribing for ages 5–19 reached 2,161 items per 1,000 (England 1,488). Contracting review coverage amid high prevalence may reflect recall capacity constraints that warrant structured clinic prioritisation.

    Cancer register and children's immunisation

    The cancer register records 1,475 patients (4.9% prevalence, England 3.8%). In Q1 2025/26, 24-month childhood immunisation trails the 95.0% target: MMR dose 1 is 83.1% (England 88.3%) and 6-in-1 is 86.2% (England 92.2%). At age 5, coverage is 92.9% for MMR dose 1 and 91.4% for dose 2 (England 82.8%), a 1.5 pp difference. Lower coverage at 24 months than at age 5 could reflect scheduling delays.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.7%

    England 91.0%

    6-in-1 complete primary course at 24 months86.2%

    England 92.2%

    MMR dose 1 at 24 months83.1%

    England 88.3%

    MMR dose 2 at age 591.4%

    England 82.8%

    4-in-1 pre-school booster at age 588.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In NHS Sussex ICB in 2022, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028. Staging completeness was 64.3% (England 67.0%). Closing the ICB gap requires about 1,360 extra early-stage diagnoses. System cervical early detection was 58.2% (England 67.6%). PCN cervical screening coverage in ages 25 to 49 is 63.8% (England 66.8%), dropping to 57.1% at Fitzalan Medical Group versus 73.0% at Coppice Surgery.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day cancer referral to treatment standard, trailing England (71.2%), NHS Surrey and Sussex Integrated Care Board (71.5%), Portsmouth Hospitals University NHS Trust (75.2%), Royal Surrey NHS Foundation Trust (84.5%) and the 85.0% standard. The trust reached 74.0% on the 28-day faster diagnosis standard (England 79.3%, Royal Surrey NHS Foundation Trust 82.6%, Portsmouth Hospitals University NHS Trust 66.8%). While 12.9% of all diagnostic tests waited 6+ weeks (England 23.1%), colonoscopy waits reached 39.3% (England 30.8%) and flexi sigmoidoscopy reached 45.4% (England 32.1%).

    Pathways within standard (%)SussexPortsmouthRoyal SurreySurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0166.8182.6279.2979.32
    31-day treatment (96%)76.7994.7896.4390.4592.50
    62-day referral to treatment (85%)65.2075.2084.4871.5171.16
    Diagnostic waits over 6 weeks (%)SussexPortsmouthRoyal SurreyEngland
    MRI5.6250.360.0021.40
    CT8.5713.060.159.92
    Echocardiography0.3932.751.5528.48
    Colonoscopy39.3582.520.0030.83
    Gastroscopy20.0274.880.0029.02
    All 15 DM01 tests12.9551.968.8223.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), West Sussex recorded 78,050 community care contacts across 19,770 patients, alongside 16,015 referrals. Adults aged 65+ accounted for 72.7% of all contacts (56,740). Across NHS Surrey and Sussex Integrated Care Board, 309,615 community care contacts were recorded for 85,660 patients. These experimental activity figures reflect local authority residents rather than registered PCN cohorts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access trails England at 23.4% and 35.9% across the two surgeries

    In 2025/26, QOF overall achievement was 92.3% at Coppice Surgery and 84.5% at Fitzalan Medical Group (England 92.5%). Vaccination and immunisation achievement reached 41.4% at Coppice Surgery and 19.4% at Fitzalan Medical Group across a 21.9 pp range (England 55.2%). Clinical achievement was 98.7% at Coppice Surgery and 92.1% at Fitzalan Medical Group.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Fitzalan Medical9127.235.9%68.3%65.6%
    Coppice Surgery1000.023.4%61.5%55.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNArunAssetPCNArun
    Care homes (catchment)39 (1,348 beds)n/aSchools (catchment)33n/a
    Children's centres37Places of worship2368
    Libraries37Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)521Primary academies919
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and respiratory review recall

    Asthma reviews are 58.5% of 2,242 patients (England 65.7%, Arun 63.2%, ICB 62.5%, falling 11.1% over 2023 to 2025, about 930 unreviewed); COPD reviews are 64.6% of 732 (England 76.4%, falling 9.3%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pharmacist-led hypertension titration and recall

    Across 5,341 hypertension patients (17.9%), under-80 BP control is 58.7% (England 67.8%, Arun 65.6%, falling 3.1% over 2023 to 2025) and 80+ control is 73.9% (England 81.2%, falling 4.1%), while 86.8% have a recent reading. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Core20 childhood immunisation and screening recall

    In Q1 2025/26 (cohort 65), 24-month MMR1 is 83.1% (England 88.3%, ICB 90.2%, 11.9 pp below the 95.0% target) and 6-in-1 is 86.2%. At Fitzalan Medical Group, age-5 MMR2 is 85.7% and cervical screening (25-49) is 57.1%. Moderate effort to run.

    Evidence base: uptake is the delivery measure of the national cancer screening programme; distance to the acceptable and achievable standards is the outreach target.

    Policy anchor: Shift 3: sickness to prevention; Eliminate cervical cancer by 2040.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Demographic and list base reconciliation (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical review outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Toddler immunisation recall audit (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma and respiratory review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Pharmacist-led hypertension titration and recall (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Core20 childhood immunisation and screening recall (p12)Core20 cohort (IMD quintile 1) · MMR dose 1 coverage at 24 months · 6-in-1 complete primary course at 24 monthsFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15